Ascendis Pharma A/S Net Foreign Exchange Gain
Ascendis Pharma A/S (ASND) reported Net Foreign Exchange Gain of EUR 78.23 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Income Statement › Other Income
ifrs-full:NetForeignExchangeGain · last filed 2026-02-11
| Period end | Net Foreign Exchange Gain 12 month |
|---|---|
| 2025-12-31 | 78.23M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | 12.35M EUR 20-F · filed 2026-02-11 |
| 2022-12-31 | 44.76M EUR 20-F · filed 2025-02-12 |
| 2021-12-31 | 59.03M EUR 20-F · filed 2024-02-07 |
| 2019-12-31 | 7.75M EUR 20-F · filed 2022-03-02 |
| 2018-12-31 | 20.69M EUR 20-F · filed 2021-03-10 |
| 2016-12-31 | 7.18M EUR 20-F · filed 2019-04-03 |
| 2015-12-31 | 11.04M EUR 20-F · filed 2018-03-28 |